Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus

Scandinavian Journal of Immunology

Volumn 64, Issue 6, 2006, Pages 668-676

  Figueroa Vega, N ^a   Galindo Rodriguez G ^b   Bajana S ^c   Portales Perez D ^a   Abud Mendoza, C ^d   Sanchez Torres C ^c   Gonzalez Amaro R ^a,e  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b Hospital of Specialties 'Dr Antonio Fraga Mouret'   (Mexico)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

^d HOSPITAL CENTRAL DR IGNACIO MORONES PRIETO   (Mexico)

^e UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD151 ANTIGEN; CD69 ANTIGEN; CD85J ANTIGEN; CD86 ANTIGEN; CD9 ANTIGEN; FIBRONECTIN; FIBRONECTIN 1; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; LYMPHOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETRASPANIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIGENS, CD; CELL DIFFERENTIATION; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; PHENOTYPE; RECEPTORS, CELL SURFACE;

EID: 33750697226     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01849.x     Document Type: Article

References (35)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52.
2. Lutz MB, Schuler G. Immature, semi-mature and fully-mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002;23:445-9.
3. Hackstein H, Morelli AE, Thomson AW. Designer dendritic cells for tolerance induction: guided not misguided missiles. Trends Immunol 2001;22:437-42.
4. Banchereau J, Pascual V, Palucka AK. Autoimmunity through cytokine-induced dendritic cell activation. Immunity 2004;20:539-50.
5. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002;80:477-83.
6. Petska S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004;22:929-79.
7. Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythemathosus. Ann Rheum Dis 2000;59:243-51.
8. Colonna M, Nakajima H, Navarro F, López-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999;66:375-81.
9. Shiroishi M, Tsumoto K, Amano K et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci USA 2003;100:8856-61.
10. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001;19:275-90.
11. Sancho D, Gómez M, Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol 2005;26:136-40.
12. Ji H, Liao G, Faubion WA et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004;172:5823-7.
13. Wright MD, Tomlinson MG. The ins and outs of transmembrane 4 superfamily. Immunol Today 1994;15:589-94.
14. Engering A, Jean P. Association of distinct tretraspanin with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int Immunol 2004;13:127-34.
15. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J 1997;11:428-42.
16. Yánez-Mo M, Mittelbrunn M, Sánchez-Madrid F. Tetraspanin and intercellular interactions. Microcirculation 2001;3:153-68.
17. Geijtenbeek TBH, van Vliet SJ, van Duijnhoven G, Figdor CG, van Kooyka Y. DC-SIGN, a dendritic cell-specific HIV-1 receptor present in placenta that infects T cells in trans - a review. Placenta 2001;15:S19-23.
18. Urban BC, Willcox N, Roberts D. A role for CD36 in the regulation of dendritic cell function. Proc Natl Acad Sci USA 2001;98:8750-5.
19. Figdor CG, Kooyk Y, Adema GJ. C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2002;2:77-84.
20. Mills JA. Systemic lupus erythematosus. N Engl J Med 1994;330:1871-9.
21. Lispky PE. Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity. Nat Immunol 2001;2:764-6.
22. Palucka AK, Banchereau J, Blanco P, Pascual V. The interplay of dendritic cell subsets in systemic lupus erythemathosus. Immunol Cell Biol 2002;80:484-8.
23. Scheinecker C, Zwölfer B, Köller M, Männer G, Smolen JS. Alterations of dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2001;44:856-65.
24. Steinbach F, Henke F, Krause B, Thiele B, Burmester GR, Hiepe F. Monocytes from systemic lupus erythematosus patients are severely altered in phenotype and lineage flexibility. Ann Rheum Dis 2000;59:283-8.
25. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
26. Guzmán J, Cardiel MH, Arce-Salinas A, Sánchez-Guerrero J, Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus: prospective validation of 3 clinical indices. J Rheumatol 1982;19:1551-8.
27. + peripheral blood monocytes. J Immunol 1996;157:3850-9.
28. Drbal K, Angelisova P, Rasmussen AM, Hilgert I, Funderud S, Horejsi V. The nature of subset of MHC class II molecules carrying the CDw78 epitopes. Int Immunol 1999;11:491-8.
29. McBride JM, Jung T, de Vries JE, Aversa G. IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses. Cell Immunol 2002;215:162-72.
30. Köller M, Zwôlfer B, Steiner G, Smolen JS, Scheinecker C. Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythemathosus (SLE) patients. Int Immunol 2004;16:1595-604.
31. Qi H, Li FR, Liu DZ et al. Study on the surface markers on peripheral blood dendritic cells and their secretion of IL-12 and IFN-alpha in SLE patients. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2005;21:499-501.
32. Akiyama Y, Suzuki T, Imai F, Ishibashi T, Fujimaki T. Low reactivity of peripheral blood dendritic cells respond to IL-1 and GM-CSF in SLE patients. Adv Exp Med Biol 1995;378:385-7.
33. Akbari O, de Kruyff RH, Umetsu DT. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001;2:725-31.
34. Chang CC, Ciubotariu R, Manavalan JS et al. Tolerization of dendritic cells by Ts cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 2002;3:237-43.
35. Esplugues E, Sancho D, Vega-Ramos J et al. Enhanced antitumor immunity in mice deficient in CD69. J Exp Med 2003;197:1093-106.